Jose H. Bedoya - Nov 30, 2021 Form 4 Insider Report for SURMODICS INC (SRDX)

Role
Director
Signature
/s/ John Manders, on behalf of Jose H. Bedoya
Stock symbol
SRDX
Transactions as of
Nov 30, 2021
Transactions value $
-$126,526
Form type
4
Date filed
12/1/2021, 09:28 AM
Next filing
Feb 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRDX Common Stock Options Exercise $119K +5.58K +24.44% $21.31 28.4K Nov 30, 2021 Direct
transaction SRDX Common Stock Sale -$245K -5.58K -19.64% $44.00 22.8K Nov 30, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRDX Stock Option (right to buy) Options Exercise $0 -5.58K -100% $0.00* 0 Nov 30, 2021 Common Stock 5.58K $21.31 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average price of 5,576 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on November 30, 2021 with sale prices ranging from $43.50 to $44.38 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 The amount beneficially owned includes 10,610 restricted stock units (RSUs) that vest on service-based vesting dates and 8,430 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
F3 Fully vested.